BRIEF published on 11/26/2024 at 00:25, 1 year 4 months ago NexgenRx Reports Q3 Growth and Announces Dividend Financial Results Revenue Increase Dividend Declaration SaaS Solutions EBITDA Growth
PRESS RELEASE published on 11/26/2024 at 00:20, 1 year 4 months ago NexgenRx Announces Third Quarter Results and Declaration of Divdend NexgenRx announces Q3 2024 financial results, with quarterly revenue up to $4,158,667 and increased positive EBITDA of $446,448. A dividend of $0.005 per share declared for shareholders Financial Results Revenue Dividend Q3 2024 NexgenRx
BRIEF published on 10/07/2024 at 23:35, 1 year 5 months ago NexgenRx Re-Appoints Charles Burns to Board of Directors Technology Solutions Board Appointment Canada NexgenRx Charles Burns
PRESS RELEASE published on 10/07/2024 at 23:30, 1 year 5 months ago NexgenRx Announces Director Re-Appointment NexgenRx Inc. announces re-appointment of Charles Burns to its Board of Directors. Company provides full-service Third-Party Administrator & Technology Solutions in Canada Board Of Directors Technology Solutions Third-party Administrator NexgenRx Inc. Charles Burns
BRIEF published on 10/01/2024 at 14:05, 1 year 5 months ago NexgenRx Appoints Linda Brennan to Board of Directors Board Of Directors Corporate Governance Appointment NexgenRx Linda Brennan
PRESS RELEASE published on 10/01/2024 at 14:00, 1 year 5 months ago NexgenRx Announces New Director NexgenRx announces the appointment of Linda Brennan as a new member to its Board of Directors. Linda brings expertise in finance and corporate governance to the company Board Of Directors Appointment Finance NexgenRx Linda Brennan
BRIEF published on 07/18/2024 at 20:05, 1 year 8 months ago NexgenRx Announces Share Issuances Under Consulting Agreement Consulting Agreement Share Issuance NexgenRx PBM Management Services SaaS Model
PRESS RELEASE published on 07/18/2024 at 20:00, 1 year 8 months ago NexgenRx Announces Share Issuances Under Consulting Agreement NexgenRx announces issuance of common shares under Consulting Agreement with PBM Management Services. Financial statements to reflect shares for period ended June 30, 2024 Financial Statements Common Shares Consulting Agreement NexgenRx PBM Management Services
BRIEF published on 05/17/2024 at 00:00, 1 year 10 months ago NexgenRx Announces Annual Meeting Results Stock Option Plan Annual Meeting Shareholder Voting Director Resignation NexgenRx Inc
PRESS RELEASE published on 05/16/2024 at 23:55, 1 year 10 months ago NexgenRx Announces Annual Meeting Results NexgenRx Inc. announces successful annual and special meeting results. Shareholders approve director appointments, auditors, and Stock Option Plan. Noteworthy election outcome Shareholders Stock Option Plan Annual Meeting Director Appointment NexgenRx Inc.
Published on 03/26/2026 at 13:00, 54 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 54 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 55 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 1 hour 9 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 1 hour 9 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 13:47, 7 minutes ago EQS-Adhoc: Ping An Insurance (Group) Company of China, Ltd.: PROPOSED DISTRIBUTION OF FINAL DIVIDEND
Published on 03/26/2026 at 13:00, 54 minutes ago Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI
Published on 03/26/2026 at 12:45, 1 hour 9 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 1 hour 34 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 07:30, 6 hours 24 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 19 hours 23 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 20 hours 9 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
